Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Sarah E. Hall is active.

Publication


Featured researches published by Sarah E. Hall.


Nature Biotechnology | 2003

Metabolic redesign of vitamin E biosynthesis in plants for tocotrienol production and increased antioxidant content

Edgar B. Cahoon; Sarah E. Hall; Kevin G. Ripp; Thaya S Ganzke; William Dean Hitz; Sean J. Coughlan

Tocotrienols are the primary form of vitamin E in seeds of most monocot plants, including cereals such as rice and wheat. As potent antioxidants, tocotrienols contribute to the nutritive value of cereal grains in human and livestock diets. cDNAs encoding homogentisic acid geranylgeranyl transferase (HGGT), which catalyzes the committed step of tocotrienol biosynthesis, were isolated from barley, wheat and rice seeds. Transgenic expression of the barley HGGT in Arabidopsis thaliana leaves resulted in accumulation of tocotrienols, which were absent from leaves of nontransformed plants, and a 10- to 15-fold increase in total vitamin E antioxidants (tocotrienols plus tocopherols). Overexpression of the barley HGGT in corn seeds resulted in an increase in tocotrienol and tocopherol content of as much as six-fold. These results provide insight into the genetic basis for tocotrienol biosynthesis in plants and demonstrate the ability to enhance the antioxidant content of crops by introduction of an enzyme that redirects metabolic flux.


Journal of Acquired Immune Deficiency Syndromes | 1999

Prospective study of HTLV-I infection in an initially asymptomatic cohort

Graham P. Taylor; Jennifer Tosswill; Estella Matutes; Susan Daenke; Sarah E. Hall; Barbara J. Bain; Ricardo Davis; Dafydd Thomas; Charles R. M. Bangham; Jonathan Weber

A prospective clinical study of 20 initially asymptomatic HTLV-I-seropositive carriers was commenced in 1991 to determine the natural history of the infection in relation to HTLV-I proviral load, immune responses, and lymphocyte phenotype. Proviral load varied widely between carriers but was relatively constant within an individual over time. The lymphocyte phenotype and prevalence of activated lymphocytes were not predictive of disease and the magnitude of the cytotoxic T-lymphocyte response to HTLV-I was independent of proviral load. Incident conditions, some related to HTLV-I infection, including a case of HTLV-I-associated myelopathy (HAM), were documented in 9 carriers. Development of myelopathy and uveitis was associated with high peripheral blood HTLV-I proviral load that predated symptoms. Persistently high proviral load appears to predate the development of HTLV-I-associated inflammation in neuro-ophthalmic tissue.


Proceedings of the Royal Society of London B: Biological Sciences | 2001

Cytotoxic T–cell abundance and virus load in human immunodeficiency virus type 1 and human T–cell leukaemia virus type 1

Dominik Wodarz; Sarah E. Hall; Koichiro Usuku; Mitsuhiro Osame; Graham S. Ogg; Andrew J. McMichael; Martin A. Nowak; Charles R. M. Bangham

The correlation between virus load and specific cytotoxic T–lymphocyte (CTL) frequency during the chronic phase in human immunodeficiency virus type 1 (HIV–1) infection has been found to be negative in cross–sectional studies. We report here that, in infection with the related retrovirus human T–cell leukaemia virus type 1 (HTLV–1), the correlation is positive in asymptomatic carriers and zero in patients with the associated inflammatory disease HTLV–1–associated myelopathy/tropical spastic paraparesis (HAM/TSP). We demonstrate that the direction of the correlation may depend on the efficacy of the CTL response using mathematical models. We conclude that the CTL response is effective in asymptomatic carriers of HTLV–1, but ineffective in patients with HAM/TSP. Virus–mediated impairment of specific CTL production in HIV–1 infection can account for the negative correlation observed.


Proceedings of the National Academy of Sciences of the United States of America | 1999

HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy

Katie Jeffery; Koichiro Usuku; Sarah E. Hall; Wataru Matsumoto; Graham P. Taylor; J. Procter; Michael Bunce; Graham S. Ogg; Kenneth I. Welsh; Jonathan Weber; Alun L. Lloyd; Martin A. Nowak; Masahiro Nagai; Daisuke Kodama; Shuji Izumo; Mitsuhiro Osame; Charles R. M. Bangham


Blood | 2000

Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes

Emmanuel Hanon; Sarah E. Hall; Graham P. Taylor; Mineki Saito; Ricardo Davis; Yuetsu Tanaka; Koichiro Usuku; Mitsuhiro Osame; Jonathan Weber; Charles R. M. Bangham


Proceedings of the National Academy of Sciences of the United States of America | 1999

Biosynthetic origin of conjugated double bonds: Production of fatty acid components of high-value drying oils in transgenic soybean embryos

Edgar B. Cahoon; Thomas J. Carlson; Kevin G. Ripp; Bruce Schweiger; George A. Cook; Sarah E. Hall; Anthony J. Kinney


Plant Physiology | 2000

Production of fatty acid components of meadowfoam oil in somatic soybean embryos.

Edgar B. Cahoon; Elizabeth-France Marillia; Kevin L. Stecca; Sarah E. Hall; David C. Taylor; Anthony J. Kinney


Journal of Virology | 1999

Effect of Lamivudine on Human T-Cell Leukemia Virus Type 1 (HTLV-1) DNA Copy Number, T-Cell Phenotype, and Anti-Tax Cytotoxic T-Cell Frequency in Patients with HTLV-1-Associated Myelopathy

Graham P. Taylor; Sarah E. Hall; S. Navarrete; C. A. Michie; Ricardo Davis; Aviva Witkover; Martin A. Nowak; Peter Rudge; Estella Matutes; Charles R. M. Bangham; Jonathan Weber


Journal of Biological Chemistry | 2001

Formation of Conjugated Δ8,Δ10-Double Bonds by Δ12-Oleic-acid Desaturase-related Enzymes BIOSYNTHETIC ORIGIN OF CALENDIC ACID

Edgar B. Cahoon; Kevin G. Ripp; Sarah E. Hall; Anthony J. Kinney


Virology | 1996

High activated and memory cytotoxic T-cell responses to HTLV-1 in healthy carriers and patients with tropical spastic paraparesis

Susan Daenke; Allan G. Kermode; Sarah E. Hall; Graham P. Taylor; Jonathan Weber; Simon Nightingale; Charles R. M. Bangham

Collaboration


Dive into the Sarah E. Hall's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Edgar B. Cahoon

United States Department of Agriculture

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Dominik Wodarz

University of California

View shared research outputs
Top Co-Authors

Avatar

Susan Daenke

John Radcliffe Hospital

View shared research outputs
Researchain Logo
Decentralizing Knowledge